CARM1 and cancer: Taken together, identification of a large cohort of CARM1 substrates with implications in a variety of biological processes which are often dysregulated in cancer, particularly in intracellular estrogen receptor signaling pathway, and the hypermethylation status observed on these proteins underscores the significance of CARM1-mediated arginine methylation in breast carcinogenesis.